Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
15 pending office actions • 7 art units • 13 examiners • 0 of 15 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Keygene N V maintains a robust portfolio with 15 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 7 distinct art units, which indicates a broad technical scope within the life sciences sector. The presence of 13 distinct examiners means that the company must manage a wide variety of examiner styles and requirements simultaneously.
KEOGH, MATTHEW R is the busiest examiner for the company, though they are responsible for only 2 pending actions. This low concentration per examiner suggests that the outcomes of the 15 pending actions are highly decentralized. Prosecution teams must be prepared for 13 different sets of examiner feedback across the 7 art units involved. The strategy must account for the specific tendencies of KEOGH, MATTHEW R while addressing the broader needs of the portfolio. With 2 actions under one official, the rest of the workload is spread thin.
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (20%) |
| §112 only | 3 (20%) |
| Double-patenting only | 1 (7%) |
| Double-patenting + other | 1 (7%) |
| Multi-statute (no §101) | 7 (47%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KEOGH, MATTHEW R | 2 | 78.3% | +14.5% |
| STOCKDALE, JESSICA NICOLE | 2 | 50.0% | +35.2% |
| SHEN, YANXIN NMN | 1 | 90.0% | +22.5% |
| ZHENG, LI | 1 | 83.6% | +12.9% |
| WILLIAMS, KEITH RICHARD | 1 | 50.0% | +0.0% |
| PAGE, BRENT T | 1 | 82.4% | +10.8% |
| MEYER, GEORGE WILLIAM | 1 | 100.0% | +0.0% |
| TURPIN, ZACHARY MARK | 1 | 4.0% | -5.0% |
| BAKSHI, PANCHAM | 1 | 76.8% | +30.2% |
| MEADOWS, CHRISTINA L | 1 | 76.1% | +23.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18757549 | Delivery systems for TNE | PAGE, BRENT T | 15d |
| 19135838 | REGENERATION BY PROTOPLAST CALLUS GRAFTING | SHEN, YANXIN NMN | — |
| 19209115 | METHOD FOR TARGETED ALTERATION OF DUPLEX DNA | ZHENG, LI | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17837904 | SEMI-SOLID STATE NUCLEIC ACID MANIPULATION | BAKSHI, PANCHAM | 16d overdue |
| 17297859 | TARGETED ENRICHMENT BY ENDONUCLEASE PROTECTION | LU, FRANK WEI MIN | 8d overdue |
| 18743454 | DOUBLE DECAPITATION OF PLANTS | STOCKDALE, JESSICA NICOLE | 13d |
| 19106659 | HYDROGEL-CARRIERS FOR INDUCTION OF PLANT MORPHOGENESIS | WILLIAMS, KEITH RICHARD | — |
| 18487025 | MOBILE ENDONUCLEASES FOR HERITABLE MUTATIONS | MEYER, GEORGE WILLIAM | — |
| 18487029 | CO-REGENERATION RECALCITRANT PLANTS | STOCKDALE, JESSICA NICOLE | — |
| 18038381 | Targeted enrichment using nanopore selective sequencing | TURPIN, ZACHARY MARK | — |
| 17118429 | NUCLEIC ACID AMPLIFICATION METHOD | YU, TIAN NMN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17837904 | SEMI-SOLID STATE NUCLEIC ACID MANIPULATION | BAKSHI, PANCHAM | 16d overdue |
| 17535297 | GENE FOR PARTHENOGENESIS | MEADOWS, CHRISTINA L | 9d overdue |
| 18743454 | DOUBLE DECAPITATION OF PLANTS | STOCKDALE, JESSICA NICOLE | 13d |
| 18757549 | Delivery systems for TNE | PAGE, BRENT T | 15d |
| 18737058 | METHOD TO INCREASE POLLEN FERTILITY | KEOGH, MATTHEW R | 28d |
| 19296788 | SHOOT REGENERATION BY OVEREXPRESSION OF CHK GENES | KEOGH, MATTHEW R | — |
| 19135838 | REGENERATION BY PROTOPLAST CALLUS GRAFTING | SHEN, YANXIN NMN | — |
| 19209115 | METHOD FOR TARGETED ALTERATION OF DUPLEX DNA | ZHENG, LI | — |
| Art Unit | Apps |
|---|---|
| 1663 | 7 |
| 1662 | 1 |
| 1637 | 1 |
| 1682 | 1 |
| 1623 | 1 |
| 1683 | 1 |
| 1681 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19296788 | SHOOT REGENERATION BY OVEREXPRESSION OF CHK GENES | KEOGH, MATTHEW R | — | §103 | Non-Final OA | — | Pending | Aug 11, 2025 |
| 19135838 | REGENERATION BY PROTOPLAST CALLUS GRAFTING | SHEN, YANXIN NMN | 1663 | §112 | Non-Final OA | — | Pending | Jun 05, 2025 |
| 19209115 | METHOD FOR TARGETED ALTERATION OF DUPLEX DNA | ZHENG, LI | 1662 | §103 | Non-Final OA | — | Pending | May 15, 2025 |
| 19106659 | HYDROGEL-CARRIERS FOR INDUCTION OF PLANT MORPHOGENESIS | WILLIAMS, KEITH RICHARD | — | §103§112 | Non-Final OA | — | Pending | Feb 26, 2025 |
| 18757549 | Delivery systems for TNE | PAGE, BRENT T | 1663 | DP | Final Rejection | 15d | Pending | Jun 28, 2024 |
| 18743454 | DOUBLE DECAPITATION OF PLANTS | STOCKDALE, JESSICA NICOLE | 1663 | §103§112 | Final Rejection | 13d | Pending | Jun 14, 2024 |
| 18737058 | METHOD TO INCREASE POLLEN FERTILITY | KEOGH, MATTHEW R | 1663 | §112 | Final Rejection | 28d | Pending | Jun 07, 2024 |
| 18487025 | MOBILE ENDONUCLEASES FOR HERITABLE MUTATIONS | MEYER, GEORGE WILLIAM | 1637 | §103§112 | Non-Final OA | — | Pending | Oct 13, 2023 |
| 18487029 | CO-REGENERATION RECALCITRANT PLANTS | STOCKDALE, JESSICA NICOLE | 1663 | §102§103 | Final Rejection | — | Pending | Oct 13, 2023 |
| 18038381 | Targeted enrichment using nanopore selective sequencing | TURPIN, ZACHARY MARK | 1682 | §112DP | Final Rejection | — | Pending | May 23, 2023 |
| 17837904 | SEMI-SOLID STATE NUCLEIC ACID MANIPULATION | BAKSHI, PANCHAM | 1623 | §102§103 | Non-Final OA | 16d overdue | Pending | Jun 10, 2022 |
| 17535297 | GENE FOR PARTHENOGENESIS | MEADOWS, CHRISTINA L | 1663 | §112 | Final Rejection | 9d overdue | Pending | Nov 24, 2021 |
| 17297859 | TARGETED ENRICHMENT BY ENDONUCLEASE PROTECTION | LU, FRANK WEI MIN | 1683 | §102§103 | Final Rejection | 8d overdue | Pending | May 27, 2021 |
| 17118429 | NUCLEIC ACID AMPLIFICATION METHOD | YU, TIAN NMN | 1681 | §103§112 | Non-Final OA | — | Pending | Dec 10, 2020 |
| 17081832 | GENES FOR HORMONE-FREE PLANT REGENERATION | BOGGS, RUSSELL T | 1663 | §103 | Non-Final OA | — | Pending | Oct 27, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial